# Servier Pharmaceuticals, LLC. – FDA Inspection, Aug 4, 2023

Source: https://www.keypedia.com/records/fda_inspections/servier-pharmaceuticals-llc/5715ce07-dbfc-4f6a-ae10-921bc97fc6b2
Source feed: FDA_Inspections

> FDA inspection 1216612 of Servier Pharmaceuticals, LLC., August 04, 2023. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216612
- Company Name: Servier Pharmaceuticals, LLC.
- Inspection Date: 2023-08-04
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1233192 - 2024-03-05
- FDA Inspection 1166452 - 2022-03-24

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/matthew-c-watson/a1594b84-f65a-42f9-a06d-a68a49eb4b28)

Company: https://www.keypedia.com/companies/servier-pharmaceuticals-llc/d72f7c9b-a32a-4c7c-97aa-89001e1341aa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c